- Home
- NCLH vs OLMA Comparison
NCLH vs OLMA Comparison
Compare NCLH & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCLH
- OLMA
- Stock Information
- Founded
- NCLH 1966
- OLMA 2006
- Country
- NCLH United States
- OLMA United States
- Employees
- NCLH N/A
- OLMA N/A
- Industry
- NCLH Marine Transportation
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- NCLH Consumer Discretionary
- OLMA Health Care
- Exchange
- NCLH Nasdaq
- OLMA Nasdaq
- Market Cap
- NCLH 12.1B
- OLMA 465.4M
- IPO Year
- NCLH 2013
- OLMA 2020
- Fundamental
- Price
- NCLH $26.92
- OLMA $6.10
- Analyst Decision
- NCLH Buy
- OLMA Strong Buy
- Analyst Count
- NCLH 16
- OLMA 5
- Target Price
- NCLH $29.27
- OLMA $26.25
- AVG Volume (30 Days)
- NCLH 9.1M
- OLMA 1.1M
- Earning Date
- NCLH 10-31-2024
- OLMA 11-12-2024
- Dividend Yield
- NCLH N/A
- OLMA N/A
- EPS Growth
- NCLH N/A
- OLMA N/A
- EPS
- NCLH 1.25
- OLMA N/A
- Revenue
- NCLH $9,356,741,000.00
- OLMA N/A
- Revenue This Year
- NCLH $13.10
- OLMA N/A
- Revenue Next Year
- NCLH $8.05
- OLMA N/A
- P/E Ratio
- NCLH $21.52
- OLMA N/A
- Revenue Growth
- NCLH 15.76
- OLMA N/A
- 52 Week Low
- NCLH $14.69
- OLMA $5.56
- 52 Week High
- NCLH $28.64
- OLMA $16.78
- Technical
- Relative Strength Index (RSI)
- NCLH 53.50
- OLMA 27.05
- Support Level
- NCLH $24.89
- OLMA $5.56
- Resistance Level
- NCLH $26.90
- OLMA $6.87
- Average True Range (ATR)
- NCLH 1.04
- OLMA 0.81
- MACD
- NCLH -0.23
- OLMA -0.28
- Stochastic Oscillator
- NCLH 56.86
- OLMA 10.12
About NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 66,500). It operates 32 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 41,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.